Tate & Lyle PLC

TATE: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
GBX 199.00TyzfrgGdczbxpj

New Morningstar Analyst Report for Tate & Lyle PLC

Business Strategy and Outlook

Tate & Lyle is a play on secular growth trends such as the increasing use of ingredients in food and beverage to remove unhealthy components (sugar, fat, salt, sodium); reduce the cost of raw materials for manufacturers and increase shelf life of the product; and satisfy the increasing number of formulations being requested by manufacturers. The business is split into speciality (38% of sales, 64% of EBIT) and bulk (62% of sales, 36% of EBIT) ingredients.

Sponsor Center